Newly-developed medication can be an effective means of curbing alcohol dependence when paired with psychological counseling, according to a new study published in JAMA.
In the first large, randomized study in the United States that tested the efficacy of FDA-approved drugs for alcohol dependents either combined with or without therapy, a large team of researchers from across the U.S. found that acamprosate (Campral) and naltrexone (Revia) successfully help users stop drinking when combined with psychological treatment. Right now, most doctors either prescribe drugs or treatment, but rarely both.
Two other drugs, nalmefene (Selincro) and topiramate (Topamax), can also help patients stop drinking, the study found.
Eight million people in the United States are currently alcohol dependent. Alcoholism can case liver and brain damage, as well as damage to other organs, and can increase the likelihood of dying early by three times.
- Volodymyr Zelensky and the Spirit of Ukraine: TIME's 2022 Person of the Year
- Mickey Guyton Is TIME's 2022 Breakthrough Artist of the Year
- The 10 Best Nonfiction Books of 2022
- Column: What Elon Musk Gets Wrong About Free Speech
- The Forgotten Story of One of the First U.S. Soldiers Killed Overseas After Pearl Harbor
- Why You're More Likely to Get Sick in the Winter, According to New Research
- Column: What the Protests Tell Us About China's Future
- 18 Last-Minute Gifts for Everyone on Your List